Asset Management Ventures (AMV)
AMV is a venture capital firm investing in early-stage digital health, tech, and life sciences companies.
Business Model:
Revenue: $20.9M
Employees: 51-200
Rankings
Detailed Asset Management Ventures (AMV) Information
Geographic Data
Address: 2100 Geng Rd
City: Palo Alto
State: CA
Zip: 94303
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$175M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
4,834,408Website Global Rank
1,774Website Monthly Traffic
Twitter Followers
Description
AMV is a venture capital firm investing in early-stage digital health, tech, and life sciences companies. The firm has provided early-stage financing for ground-breaking companies such as Amgen, Tandem Computer, and Applied BioSystems. Asset Management was founded in 1965 by venture capitalist Franklin "Pitch" Johnson in Palo Alto, California.
Contact Phone:
+16506218808
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2016 | ViewPoint Therapeutics | Series A | 0 |
| 1/2010 | HighTower Advisors | Equity | 100M |
| 2/2017 | Welkin Health | Series A | - |
| 7/2016 | InCarda Therapeutics | Venture Round | - |
| 6/2014 | Biomimedica | Venture Round | 250k |
| 11/2016 | Womply | Series B | 30M |
| 7/2007 | Stratavia | Series B | 6.3M |
| 8/2005 | Stratavia | Series A | 3.3M |
| 2/2012 | KeepSafe | Seed Round | 700k |
| 12/2011 | HealthTap | Series A | 11.5M |
| 6/2011 | ICON Aircraft | Series C | 25M |
| 5/2015 | Thunder | Venture Round | 1.8M |
| 4/2017 | Thunder | Series B | - |
| 5/2014 | Mozio | Seed | 750k |
| 7/2016 | Mozio | Non Equity Assistance | 0 |
| 6/2014 | Benefitter | Debt Financing | 4.4M |
| 7/2022 | Carta Healthcare | Series B | 0 |
| 6/2015 | Twist Bioscience | Series C | 37M |
| 1/2014 | Womply | Venture Round | - |
| 6/2013 | Evidation Health | Seed Round | - |
| 5/2013 | Synecor | Venture Round | - |
| 8/2008 | Proteus Digital Health | Series D | 28.6M |
| 1/2006 | Proteus Digital Health | Series C | 33M |
| 8/2010 | Provade, Inc. | Series F | 2.7M |
| 7/2015 | Welkin Health | Seed Round | 0 |
| 9/2013 | Profusa | Venture Round | 2.8M |
| 10/2018 | Properly | Series A | 0 |
| 1/2022 | Pluto Health | Seed Round | 6.4M |
| 3/2017 | Freenome | Series A | 65M |
| 11/2020 | Outcomes4Me | Seed | 4.7M |
| 3/2013 | Reify Health | Debt Financing | 330k |
| 2/2017 | 3T Biosciences | Convertible Note | - |
| 6/2012 | Reify Health | Seed Round | 500k |
| 11/2004 | Chimerix | Series C | 11M |
| 1/2010 | Kii Corporation | Series A | - |
| 5/2007 | Sonoma Orthopedics | Series B | 10M |
| 1/2021 | Aavia | Seed Round | 2.5M |
| 12/2009 | Stratavia | Debt Financing | 450k |
| 11/2003 | iS3 | Series B | 9.1M |
| 2/2011 | Chimerix | Series F | 45M |
| 4/2004 | Virtio | Series C | - |
| 3/2017 | Twist Bioscience | Venture Round | 33M |
| 6/2012 | Rock Health | Grant | 500k |
| 6/2013 | Arterys | Seed Round | - |
| 7/2019 | Arterys | Convertible Note | - |
| 10/2006 | Novare Surgical | Series D | 16M |
| 12/2009 | Coapt Systems | Debt Financing | 3.7M |
| 1/2020 | Secure AI Labs | Pre Seed Round | 3.4M |
| 12/2015 | Arterys | Series A | 7M |
| 9/2015 | Thunder | Series B | 7M |
| 10/2013 | Lark | Seed Round | 3.1M |
| 3/2019 | Carta Healthcare | Convertible Note | - |
| 12/2014 | Evidation Health | Series A | 6M |
| 3/2007 | Coapt Systems | Series E | 22.6M |
| 6/2009 | Ooma | Series D | 19M |
| 6/2004 | Proteus Digital Health | Series B | 6.3M |
| 10/2009 | Brilliant Telecommunications | Venture Round | 0 |
| 3/2014 | Reify Health | Seed Round | 1.3M |
| 1/2005 | Get Connected Inc | Series D | 0 |
| 12/2001 | Talkway Communications | Series B | 0 |
| 4/2012 | Terra Bella | Series C | 70M |
| 10/2015 | Audentes Therapeutics | Series C | 65M |
| 7/2019 | UniKey Technologies | Convertible Note | - |
| 9/2009 | Yamei Electronics | Seed Round | - |
| 5/2013 | Proteus Digital Health | Series F | 62.5M |
| 6/2009 | Provade, Inc. | Series E | 3.2M |
| 3/2010 | OfferIQ | Venture Round | - |
| 6/2017 | Indi Molecular | Series A | 0 |
| 3/2003 | iScience Surgical | Series B | 0 |
| 10/2013 | Lark | Venture Round | 3.1M |
| 5/2006 | ViaCyte | Venture Round | 0 |
| 5/2013 | HealthTap | Series B | 24M |
| 10/2013 | LiquidM | Series A | 5M |
| 2/2014 | Twist Bioscience | Series A | 9.1M |
| 8/2012 | CardioDx | Private Equity Round | 58M |
| 5/2019 | Welkin Health | Series B | 17.5M |
| 7/2015 | 1DocWay | Seed Round | 0 |
| 8/2008 | InteKrin | Series C | 0 |
| 9/2010 | Rapidscan Pharma Solutions | Series A | 2.4M |
| 11/2017 | Aegis Surgical | Convertible Note | - |
| 1/2007 | Athena Design Systems | Series B | 0 |
| 1/2007 | InteKrin | Series B | 0 |
| 7/2013 | KeepSafe | Series A | 3.4M |
| 7/2014 | LiquidM | Venture Round | 3.7M |
| 5/2009 | iScience Interventional | Series F | 20.5M |
| 10/2002 | Corrigo | Venture Round | - |
| 7/2014 | CardioDx | Private Equity Round | 21M |
| 12/2015 | Welldoc | Series B | 0 |
| 4/2007 | Sonoma Orthopedics | Series A | 3M |
| 6/2005 | Corrigo | Venture Round | 10M |
| 12/2015 | RallyPoint | Series B | 5M |
| 12/2015 | Profusa | Series B | 13.2M |
| 8/2009 | Chimerix | Series E | 16.1M |
| 6/2007 | Koronis Pharmaceuticals | Series D | 20M |
| 11/2018 | InCarda Therapeutics | Series B | 42M |
| 2/2007 | Chimerix | Series D | 23.1M |
| 7/2007 | ViaCyte | Series C | 0 |
| 2/2007 | Brilliant Telecommunications | Series A | 7.1M |
| 10/2003 | Corrigo | Venture Round | 6.7M |
| 1/2000 | Prime Advantage | Series B | 7.3M |
| 10/2020 | Lark | Series C | 55M |
| 4/2004 | Corrigo | Venture Round | - |
| 10/2013 | RallyPoint | Series A | 5.3M |
| 6/2017 | UniKey Technologies | Convertible Note | 5M |
| 4/2015 | UniKey Technologies | Series A | 10M |
| 4/2021 | Outcomes4Me | Series A | 0 |
| 3/2016 | Arterys | Series A | 5M |
| 1/2016 | Aegis Surgical | Series B | 5.6M |
| 5/2019 | Mightier | Series A | 0 |
| 1/2011 | Ooma | Debt Financing | 0 |
| 11/2014 | CardioGen Sciences | Seed Round | 526k |
| 5/2017 | Amygdala Neuroscience | Seed Round | - |
| 12/2004 | BiPar Sciences | Series A | 13M |
| 1/2009 | BiPar Sciences | Series C | 20M |
| 2/2007 | BiPar Sciences | Series B | 35M |
| 4/2013 | Esperion | Venture Round | 33M |
| 5/2010 | CardioDx | Series D | 34.5M |
| 8/2014 | Womply | Venture Round | 20M |
| 8/2000 | Prime Advantage | Series C | 0 |
| 1/2001 | Talkway Communications | Series A | 10M |
| 11/2020 | Secure AI Labs | Seed Round | - |
| 7/2022 | Secure AI Labs | Seed Round | 4.7M |
| 10/2022 | SubjectWell | Series B | 35M |
| 3/2011 | HealthTap | Seed Round | 2.4M |
| 8/2020 | Reify Health | Series B | 30M |
| 10/2017 | 3T Biosciences | Seed Round | 12M |
| 4/2021 | Carta Healthcare | Series A | 17.3M |
| 9/2020 | Decent | Series A | 0 |
| 8/2017 | Freenome | Series A | 7M |
| 5/2014 | Twist Bioscience | Series B | 26M |
| 7/2012 | CardioDx | Private Equity Round | 0 |
| 12/2002 | VetCentric | Venture Round | 14.5M |
| 12/2009 | Servo Software | Series B | 3M |
| 6/2016 | Evidation Health | Series B | 11.6M |
| 3/2014 | Aegis Surgical | Venture Round | - |
| 5/2004 | CAPNIA | Series B | 12M |
| 4/2008 | LOOMIA | Series A | 5M |
| 5/2015 | Aegis Surgical | Convertible Note | - |
| 1/2016 | Sensomics | Seed Round | 600k |
| 9/2017 | Huiseoul | Seed Round | - |
| 6/2008 | Biomimedica | Series A | 2.4M |
| 4/2019 | Signal Vine | Convertible Note | - |
| 9/2019 | Unnatural Products | Seed Round | 0 |
| 7/2017 | Signal Vine | Series A | 2M |
| 1/2014 | Maverix Biomics | Series A | 6M |
| 6/2012 | Biomimedica | Series B | 0 |
| 7/2014 | Signal Vine | Seed Round | 249.3k |
| 1/2013 | Arterys | Seed Round | 1.7M |
| 6/1999 | Prime Advantage | Venture Round | 800k |
| 12/2013 | Indi Molecular | Seed Round | 300k |
| 4/2015 | Amygdala Neuroscience | Venture Round | - |
| 8/2017 | Huiseoul | Convertible Note | - |
| 3/2011 | ImmunoCellular Therapeutics | Venture Round | 8.1M |
| 4/2008 | Loomia | Series A | 5M |
| 9/2019 | Aegis Surgical | Convertible Note | - |
| 1/2022 | Pluto Health | Seed Round | 0 |
| 4/2021 | Outcomes4Me | Series A | 0 |
| 4/2021 | Carta Healthcare | Series A | 0 |
| 1/2021 | Aavia | Seed Round | 0 |
| 11/2020 | Secure AI Labs | Seed Round | - |
| 11/2020 | Outcomes4Me | Seed Round | 0 |
| 10/2020 | Lark | Series C | 0 |
| 9/2020 | Decent | Series A | 0 |
| 8/2020 | Reify Health | Series B | 0 |
| 9/2019 | Unnatural Products | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
